Company
Headquarters: Dallas, TX, United States
Employees: 35
CEO: Mr. Winston Lee Black III
$218.9 Million
USD as of Jan. 1, 2024
Company | Market Cap (USD) |
---|---|
Blackstone | $147.99 B |
BlackRock | $116.92 B |
KKR & Co. Inc. | $71.02 B |
Brookfield Corporation | $60.42 B |
The Bank of New York Mellon Corporation | $40.00 B |
Company | Market Cap (USD) |
---|---|
Berkshire Hathaway | $797.77 B |
Visa | $530.20 B |
JPMorgan | $495.55 B |
Mastercard | $392.71 B |
Bank of America | $267.48 B |
SWK Holdings Corporation, a specialty finance company, focuses on the healthcare sector. The company operates in two segments, Finance Receivables and Pharmaceutical Development. It provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. The company, through its subsidiary, SWK Advisors LLC, offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. The company also engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Its product pipeline includes Ovarest, an oral leuprolide tablet to treat endometriosis; and Tobrate, an oral tobramycin tablet for the treatment of uncomplicated urinary tract infections. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was incorporated in 1996 and is headquartered in Dallas, Texas.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
SWK Holdings Corporation has the following listings and related stock indices.
Stock: NASDAQ: SWKH wb_incandescent